Specification: |
? Butenafine HCl , with CAS number of 15663-27-1, can be called Cisplatin;cis-Platinous diamine dichloroplatin ; cis-Diamminedichloroplatinum(II) ; cis-Platinous diaminodichloride ; cis-Platinum diamminedichloride ; cis-diamminediChlorideplatinum ; Platinum, diamminedichloro-, cis- ; cis-Platin ; Platinum diamminodichloride ; Platidiam ; cis Diamminedichloroplatinum ; Platiblastin ; cis-Dichlorodiammineplatinum ; cis-Dichlorodiamine platinum ; Cisplatino ; cis-Platinum(II) diamine dichloride ; Cisplatyl ; (SP-4-2)-diamminedichloroplatinum ; Platinum(II), diamminedichloro-, cis- ; cis-Dichlorodiamminoplatinum(II) ; cis-dichlorodi-ammine platinum(ii) ; azane; platinum(+2) cation; dichloride . It is an?orange-yellow to deep yellow solid or powder,?can be used as an antineoplastic,?Cisplatin (CAS NO.15663-27-1) combine with DNA, causing cross-linking, thereby undermining the function of DNA and inhibition of cell mitosis, as a cell non-specific drugs. The broader spectrum of anti-tumor products, for head and neck squamous cell carcinoma, ovarian carcinoma, embryonic carcinoma cells, sperm immunogenicity cell tumor, lung cancer, thyroid cancer, lymphosarcoma and reticular cell sarcoma.?Cisplatin is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas , lymphomas and germ cell tumors. Cisplatin is administered intravenously as short-term infusion in physiological saline for treatment of solid malignacies.
|